Search research articles
Contact Us
Filters
Showing results (41-50 of 100) with videos related to
Page
of 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2011
New drugs for ovarian cancer
K Bell-McGuinn, J Konner, W Tew, et al.
Cancer Research
|
August 1, 1985
Continuous infusion of high-dose 1-beta-D-arabinofuranosylcytosine: a phase I and pharmacological study
D R Spriggs, G Robbins, T Takvorian, et al.
Cancer Research
|
March 27, 1998
BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II)
A Husain, G He, E S Venkatraman, et al.
Gynecologic Oncology
|
August 12, 1998
Lisofylline sensitizes p53 mutant human ovarian carcinoma cells to the cytotoxic effects of cis-diamminedichloroplatinum (II)
A Husain, N Rosales, G K Schwartz, et al.
Cancer Research
|
December 11, 1997
Posttranscriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine-rich elements in the 3'-untranslated region of tumor necrosis factor-alpha messenger RNA
E Wang, W J Ma, C Aghajanian, et al.
Gynecologic Oncology
|
October 24, 1998
Gastrointestinal toxicity and Clostridium difficile diarrhea in patients treated with paclitaxel-containing chemotherapy regimens
A Husain, L Aptaker, D R Spriggs, et al.
Cancer Drug Delivery
|
January 1, 1986
Low dose ara-C administered by continuous subcutaneous infusion: a pharmacologic evaluation
D R Spriggs, J E Sokal, J Griffin, et al.
Ciba Foundation Symposium
|
January 1, 1987
Clinical studies with tumour necrosis factor
D R Spriggs, M L Sherman, E Frei, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1990
Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha
D B Dubravec, D R Spriggs, J A Mannick, et al.
Cancer Research
|
November 1, 1985
Inhibition of murine erythroleukemia cell differentiation by 3-deazaadenosine
M L Sherman, T D Shafman, D R Spriggs, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 100) with videos related to
Sort By:
Page
of 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2011
New drugs for ovarian cancer
K Bell-McGuinn, J Konner, W Tew, et al.
Cancer Research
|
August 1, 1985
Continuous infusion of high-dose 1-beta-D-arabinofuranosylcytosine: a phase I and pharmacological study
D R Spriggs, G Robbins, T Takvorian, et al.
Cancer Research
|
March 27, 1998
BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II)
A Husain, G He, E S Venkatraman, et al.
Gynecologic Oncology
|
August 12, 1998
Lisofylline sensitizes p53 mutant human ovarian carcinoma cells to the cytotoxic effects of cis-diamminedichloroplatinum (II)
A Husain, N Rosales, G K Schwartz, et al.
Cancer Research
|
December 11, 1997
Posttranscriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine-rich elements in the 3'-untranslated region of tumor necrosis factor-alpha messenger RNA
E Wang, W J Ma, C Aghajanian, et al.
Gynecologic Oncology
|
October 24, 1998
Gastrointestinal toxicity and Clostridium difficile diarrhea in patients treated with paclitaxel-containing chemotherapy regimens
A Husain, L Aptaker, D R Spriggs, et al.
Cancer Drug Delivery
|
January 1, 1986
Low dose ara-C administered by continuous subcutaneous infusion: a pharmacologic evaluation
D R Spriggs, J E Sokal, J Griffin, et al.
Ciba Foundation Symposium
|
January 1, 1987
Clinical studies with tumour necrosis factor
D R Spriggs, M L Sherman, E Frei, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1990
Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha
D B Dubravec, D R Spriggs, J A Mannick, et al.
Cancer Research
|
November 1, 1985
Inhibition of murine erythroleukemia cell differentiation by 3-deazaadenosine
M L Sherman, T D Shafman, D R Spriggs, et al.
Page
of 10